Diagnostic Delay in Soft Tissue Sarcomas: A Review

Simple Summary Diagnostic delay in soft tissue sarcomas is a common event with important prognostic implications. The authors review the available literature to obtain a general picture of its incidence, causes, and consequences. In addition, available clinical referral guidelines for early suspicion and referral have been proposed but have not provided the desired results. The authors review different proposed methods to improve results while avoiding a collapse of the system.

• Publication year

  2025

• Venue

  Cancers

• Publication date

  2025-05-31

• Fields of study

  Medicine

• Identifiers
  DOI 10.3390/cancers17111861PMID 40507342PMCID 12153902
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pain Accelerates, Swelling and Sensory Disturbances Delay Diagnosis in Mesenchymal Tumors

  2025cited by this paper
• Orthopedic Surgeons at Greater Risk of Malpractice Claims for Treatment of Primary Malignant Bone and Soft Tissue Tumors Compared With Metastatic Bone Disease

  2024cited by this paper
• Delays in diagnosis and surgery of sarcoma patients during the COVID-19 outbreak in Spain

  2024cited by this paper
• Unplanned Sarcoma Excisions: Understanding How They Happen

  2024cited by this paper
• Is Unplanned Excision of Soft Tissue Sarcomas Associated with Worse Oncological Outcomes?—A Systematic Review and Meta-Analysis

  2024influential reference
• Clinical activity in general practice before sarcoma diagnosis: an Australian cohort study

  2024cited by this paper
• Barriers to cancer treatment for people experiencing socioeconomic disadvantage in high-income countries: a scoping review

  2024influential reference
• The prediagnostic general practitioner care of sarcoma patients: A real‐world data study

  2024cited by this paper
• The Influence of Danish Cancer Patient Pathways on Survival in Deep-Seated, High-Grade Soft-Tissue Sarcomas in the Extremities and Trunk Wall: A Retrospective Observational Study

  2024cited by this paper
• Real-world Referral Pattern of Unplanned Excision in Patients With Soft-tissue Sarcoma: A Multicenter Study Conducted by the Bone and Soft-tissue Tumor Study Group of the Japan Clinical Oncology Group

  2024cited by this paper
• Barriers to care for musculoskeletal sarcoma patients: a public health perspective

  2024influential reference
• Integrated Care in Specialized Networks: Leveraging Early Referrals to Reduce Local Recurrence in Soft Tissue Sarcoma

  2024cited by this paper
• National Cancer Diagnosis Audits for England 2018 versus 2014: a comparative analysis

  2023cited by this paper
• Benchmarking Time-to-Treatment Initiation in Sarcoma Care Using Real-World-Time Data

  2023influential reference
• Soft tissue tumor imaging in adults: European Society of Musculoskeletal Radiology-Guidelines 2023—overview, and primary local imaging: how and where?

  2023cited by this paper
• The presenting symptom signatures of incident cancer: evidence from the English 2018 National Cancer Diagnosis Audit

  2023cited by this paper
• The Next Frontier in Sarcoma Care: Digital Health, AI, and the Quest for Precision Medicine

  2023cited by this paper
• Enhancing Healthcare for Sarcoma Patients: Lessons from a Diagnostic Pathway Efficiency Analysis

  2023influential reference
• Patients’ Experiences of a Sarcoma Diagnosis: A Process Mapping Exercise of Diagnostic Pathways

  2023cited by this paper
• Telemedicine in Care of Sarcoma Patients beyond the COVID-19 Pandemic: Challenges and Opportunities

  2023cited by this paper
• Critical Review of Oncologic Medical Malpractice Claims Against Orthopaedic Surgeons

  2023cited by this paper
• Effects of time to treatment initiation on outcomes for soft tissue sarcomas

  2023influential reference
• The Implications of an Unplanned Sarcoma Excision (the "Whoops" Operation).

  2022cited by this paper
• Determinants and impact of diagnostic interval in bone sarcomas: A retrospective cohort study

  2022influential reference
• Incidence and survival of soft tissue sarcoma in England between 2013 and 2017, an analysis from the National Cancer Registration and Analysis Service

  2022influential reference
• Review of the referral documents of patients with malignant soft tissue tumors

  2022influential reference
• Effect of Insurance Status on Mortality in Adults With Sarcoma of the Extremities and Pelvis: A SEER-Medicare Study

  2022influential reference
• The computer application «SCAE» in the early diagnosis of musculoskeletal cancer in the healthcare area of the Hospital Universitario 12 de Octubre. Analysis of its effectiveness and proposals for improvement

  2022cited by this paper
• Diagnostic delay in soft tissue tumors: a single-center study of a university cancer center with a focus on health services research

  2022cited by this paper
• Soft tissue sarcoma: Recognizing a rare disease

  2022cited by this paper
• Shortening the Time Interval for the Referral of Patients With Soft Tissue Sarcoma to Expert Centers Using Mobile Health: Retrospective Study

  2022cited by this paper
• Progress and priorities in reducing the time to cancer diagnosis

  2022cited by this paper
• The impact of lag time to cancer diagnosis and treatment on clinical outcomes prior to the COVID-19 pandemic: A scoping review of systematic reviews and meta-analyses

  2022cited by this paper
• Japanese Orthopaedic Association (JOA) clinical practice guidelines on the management of soft tissue tumors 2020 - Secondary publication.

  2022cited by this paper
• Patients with an increased time to treatment initiation have a poorer overall survival after definitive surgery for localized high-grade soft-tissue sarcoma in the extremity or trunk : report from the National Cancer Database.

  2021influential reference
• Urgent cancer referrals: how well are they working and can they be improved?

  2021cited by this paper
• A virtual multi-disciplinary meeting is a cost-effective method of triaging referrals to a regional musculoskeletal oncology service

  2021cited by this paper
• The computer application «SCAE» in the early diagnosis of musculoskeletal cancer in the healthcare area of the Hospital Universitario 12 de Octubre. Analysis of its effectiveness and proposals for improvement.

  2021influential reference
• Determinants of the access to remote specialised services provided by national sarcoma reference centres

  2021cited by this paper
• Impact of NICE guidelines on the survival of patients with soft-tissue sarcomas.

  2021cited by this paper
• Disparities in Cancer Care: The Example of Sarcoma-In Search of Solutions for a Global Issue.

  2021influential reference
• Trends and variation in urgent referrals for suspected cancer 2009/2010–2019/2020

  2021influential reference
• Soft tissue masses: distribution of entities and rate of malignancy in small lesions

  2021influential reference
• Diagnosed with a Rare Cancer: Experiences of Adult Sarcoma Survivors with the Healthcare System—Results from the SURVSARC Study

  2021cited by this paper
• Is There an Association Between Insurance Status and Survival and Treatment of Primary Bone and Extremity Soft-Tissue Sarcomas? A SEER Database Study.

  2020influential reference
• Patient and diagnostic intervals of survivors of sarcoma: Results from the SURVSARC study

  2020cited by this paper
• Has the Affordable Care Act Been Associated with Increased Insurance Coverage and Early-stage Diagnoses of Bone and Soft-tissue Sarcomas in Adults?

  2020cited by this paper
• Delayed Diagnosis Is the Primary Cause of Sarcoma Litigation: Analysis of Malpractice Claims in the United States.

  2020cited by this paper
• The sarcoma diagnostic interval: a systematic review on length, contributing factors and patient outcomes

  2020influential reference
• Assessment of Familiarity With Work-up Guidelines for Bone and Soft Tissue Sarcoma Among Primary Care Practitioners in Minnesota

  2020cited by this paper
• Delayed Initiation of Treatment Is Associated With Metastasis of Soft-tissue Sarcoma

  2020cited by this paper
• Mortality due to cancer treatment delay: systematic review and meta-analysis

  2020influential reference
• CORR Insights®: Delayed Diagnosis Is the Primary Cause of Sarcoma Litigation: Analysis of Malpractice Claims in the United States.

  2020cited by this paper
• Patient non-attendance at urgent referral appointments for suspected cancer and its links to cancer diagnosis and one year mortality: A cohort study of patients referred on the Two Week Wait pathway.

  2019influential reference
• Development of a risk assessment model to differentiate malignant and benign musculoskeletal soft‐tissue masses on magnetic resonance imaging

  2019cited by this paper
• Rural patients are at risk for increased stage at presentation and diminished overall survival in osteosarcoma.

  2019cited by this paper
• Time to treatment initiation and survival in adult localized, high‐grade soft tissue sarcoma

  2019cited by this paper
• Small soft tissue masses indeterminate at imaging: histological diagnoses at a tertiary orthopedic oncology clinic

  2019cited by this paper
• Adult soft tissue sarcoma and time to treatment initiation: An analysis of the National Cancer Database

  2018influential reference
• The Aarhus statement on cancer diagnostic research: turning recommendations into new survey instruments

  2018cited by this paper
• Diagnosing cancer in primary care: results from the National Cancer Diagnosis Audit

  2017cited by this paper
• Imaging investigations before referral to a sarcoma center delay the final diagnosis of musculoskeletal sarcoma

  2017influential reference
• Socioeconomic measures influence survival in osteosarcoma: an analysis of the National Cancer Data Base.

  2017influential reference
• Evaluating Soft-Tissue Lumps and Bumps.

  2017cited by this paper
• Association of socioeconomic and practical unmet needs with self-reported nonadherence to cancer treatment appointments in low-income Latino and Black cancer patients

  2016cited by this paper
• A Comprehensive Single Institutional Review of 2 Years in a Designated Fast-Track Sarcoma Diagnostic Clinic Linked with a Sarcoma Specialist Advisory Group: Meeting the Target but Failing the Task?

  2016influential reference
• Delayed diagnosis in primary care—The main cause of sarcoma litigation in the United Kingdom

  2016cited by this paper
• Routes to Diagnosis for Suspected Sarcoma: The Impact of Symptoms and Clinical Findings on the Diagnostic Process

  2016influential reference
• Pre-referral GP consultations in patients subsequently diagnosed with rarer cancers: a study of patient-reported data

  2016influential reference
• Neglected orthopedic oncology--Causes, epidemiology and challenges for management in developing countries.

  2015cited by this paper
• Diagnostic triage for sarcoma: an effective model for reducing referrals to the sarcoma multidisciplinary team.

  2015cited by this paper
• Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes? Systematic review

  2015cited by this paper
• Racial Disparities in Extremity Soft-Tissue Sarcoma Outcomes: A Nationwide Analysis

  2015cited by this paper
• Understanding missed opportunities for more timely diagnosis of cancer in symptomatic patients after presentation

  2015cited by this paper
• Unplanned excision of soft-tissue sarcomas: current concepts for management and prognosis.

  2015cited by this paper
• Litigation in musculoskeletal oncology

  2015cited by this paper
• If your lump is bigger than a golf ball and growing, think Sarcoma.

  2015influential reference
• One-year mortality in patients with bone and soft tissue sarcomas as an indicator of delay in presentation.

  2015influential reference
• The relative length of the patient and the primary care interval in patients with 28 common and rarer cancers

  2015cited by this paper
• Evaluating the British sarcoma referral form.

  2015cited by this paper
• Routes to diagnosis for sarcoma - Describing the sarcoma patient journey.

  2015cited by this paper
• Association of Short Duration From Initial Symptoms to Specialist Consultation With Poor Survival in Soft-Tissue Sarcomas

  2015cited by this paper
• [Health care circuit for patients with soft tissue sarcomas of the extremities. A tortuous and slow road to referral units].

  2014cited by this paper
• Medical malpractice and sarcoma care—A thirty‐three year review of case resolutions, inciting factors, and at risk physician specialties surrounding a rare diagnosis

  2014cited by this paper
• Rethinking diagnostic delay in cancer: how difficult is the diagnosis?

  2014influential reference
• Effect of marital status on treatment and survival of extremity soft tissue sarcoma.

  2014cited by this paper
• The impact of a managed clinical network on referral patterns of sarcoma patients in Grampian

  2014cited by this paper
• Alarm symptoms of soft-tissue and bone sarcoma in patients referred to a specialist center

  2014cited by this paper
• Lessons Learned From the Study of 10,000 Patients With Soft Tissue Sarcoma

  2014cited by this paper
• Implementation and assessment of a fast-track programme to improve communication between primary and specialized care in patients with suspected cancer: how to shorten time between initial symptoms of cancer, diagnosis and initiation of treatment

  2014cited by this paper
• Circuito de asistencia a pacientes con sarcomas de partes blandas de las extremidades: un tortuoso y lento camino hasta las unidades de referencia

  2014cited by this paper
• Cancer Patient Pathways shortens waiting times and accelerates the diagnostic process of suspected sarcoma patients in Denmark.

  2013cited by this paper
• The model of pathways to treatment: conceptualization and integration with existing theory.

  2013cited by this paper
• Measures of promptness of cancer diagnosis in primary care: secondary analysis of national audit data on patients with 18 common and rarer cancers

  2013influential reference
• The Andersen Model of Total Patient Delay: a systematic review of its application in cancer diagnosis

  2012cited by this paper
• Early symptoms of bone and soft tissue sarcomas: could they be diagnosed earlier?

  2012cited by this paper
• An Epidemiological Study on Delay in Treatment Initiation of Cancer Patients

  2012cited by this paper
• The Aarhus statement: improving design and reporting of studies on early cancer diagnosis

  2012cited by this paper
• A retrospective statistical analysis of high-grade soft tissue sarcomas

  2012influential reference
• Assessment of Referrals into the Soft Tissue Sarcoma Service: Evaluation of Imaging Early in the Pathway Process

  2012cited by this paper

• An Explainable Radiomics-Based Classification Model for Sarcoma Diagnosis

  2025cites this paper
• Demographics and Clinical Profile of Patients Admitted to a Palliative Care Unit of a Tertiary Cancer Center in Nepal

  2025cites this paper